Switzerland / Swissmedic: Taking Its Own Path
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in terms of the evaluation and approval of new drugs,…
Brazil / EMS Sales Soar; Irregularities in Indian Vaccine Deal; Personalised Medicine Challenges
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat Biotech to purchase COVID-19 vaccines; the IP and regulatory challenges around personalised medicine…
China / New Country President for MSD Amid Changes at HQ & Access Challenges
MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its strategically important China business. van Acker takes the helm against…
CEE / EU’s Beating Cancer Plan: Making it Our Own
Jasper Kunow, MSD’s managing director for Central Eastern Europe, outlines the threat that cancer still poses to Europe, the challenges of enacting the EU’s Beating Cancer Plan across the CEE…
Indonesia / National Pharma Champion Optimistic of COVID-Related Growth
With a market value of USD 5.2 billion, Kalbe Farma has consolidated into Indonesia’s undisputed national pharma champion and has established a footprint in many ASEAN countries as well as…
Denmark / A Life Sciences Force to Be Reckoned With
On April 16, the Danish government unveiled, to great anticipation and fanfare, a brand-new National Life Science Strategy which seeks to chart the course for the next three years of…
Egypt / Trade Deficit Plummets; Big UAE Investments; Vaccine Manufacturing Developments
As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been allowed to leave Egypt. The infamous episode illustrated…
Switzerland / Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the digestive system, has overseen a number of acquisitions and the growth of…
USA / Impact of COVID-19 on US Clinical Studies Conducted by Japan-Based Pharmaceutical Companies
Writing in the June edition of DIA’s Global Forum magazine, representatives of Japanese pharmaceutical companies with US operations outline how the COVID-19 pandemic affected their ongoing clinical studies. The…
China / A New Era of Reform Transforming Regulatory Professionals
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation with Sanofi China’s Irene Deng, looks at how Chinese pharmaceutical regulations have evolved and…
Mexico / Bayer Targets Cancer; Novartis Gets Aggressive; J&J Vaccines Arrive; Doctors Denied Jabs
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the country’s vaccination drive, including the upcoming rollout…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual conference, and how the US generics and biosimilars industry might…